Medications & Supplements/Prescription Drugs

Teva Pharmaceuticals USA: Moexipril Hydrochloride and HCTZ Tablets Recalled for Impurity Levels

Agency Publication Date: January 8, 2018

Summary

Teva Pharmaceuticals USA is recalling 4,969 bottles of Moexipril Hydrochloride and Hydrochlorothiazide Tablets (7.5 mg/12.5 mg), a prescription medication used to treat high blood pressure. The recall was initiated because routine stability testing found that a specific impurity, Moexipril Diketopiperazine, exceeded safe specification limits over time. Consumers should contact their doctor or pharmacist to discuss alternative treatments while the affected medication is removed from use.

Risk

The presence of higher-than-expected levels of the Moexipril Diketopiperazine impurity means the drug may degrade faster than intended, potentially affecting the medication's potency or safety profile over the long term.

What You Should Do

Check your prescription bottle for Moexipril Hydrochloride and Hydrochlorothiazide Tablets USP, 7.5 mg/12.5 mg in 100-count bottles with NDC 0093-5213-01.
Verify if your bottle belongs to Lot # 30229439A with an expiration date of 12/17 (December 2017).
If you have the affected medication, contact your healthcare provider or pharmacist immediately for guidance on a replacement or alternative treatment.
Return any unused portion of the affected lot to your pharmacy to receive a refund.
Contact Teva Pharmaceuticals USA at 1-888-838-2872 for further instructions or information regarding this recall.
For additional questions or to report adverse reactions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Pharmacy refund and medical consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Moexipril Hydrochloride and Hydrochlorothiazide Tablets USP, 7.5 mg/12.5 mg (100-count bottle)

Model:

NDC 0093-5213-01

Recall #: D-0208-2018

Lot Numbers:

30229439A (Exp 12/17)

Date Ranges: Expiration Date 12/17

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 78753

Status: Resolved

Manufacturer: Teva Pharmaceuticals USA

Sold By: Pharmacies

Manufactured In: United States

Units Affected: 4,969 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your prescription bottle for Moexipril Hydrochloride and Hydrochlorothiazide Tablets USP, 7.5 mg/12.5 mg in 100-count bottles with NDC 0093-5213-01.

Verify if your bottle belongs to Lot # 30229439A with an expiration date of 12/17 (December 2017).

If you have the affected medication, contact your healthcare provider or pharmacist immediately for guidance on a replacement or alternative treatment.

Return any unused portion of the affected lot to your pharmacy to receive a refund.

Contact Teva Pharmaceuticals USA at 1-888-838-2872 for further instructions or information regarding this recall.

For additional questions or to report adverse reactions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.